Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab vs MMF in Children with Refractory Nephrotic Syndrome
NCT02390362Phase 3Terminated
- Sponsor
- Nationwide Children's Hospital
- Start
- Jan 2015
- Primary completion
- Dec 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in nephrotic syndrome, sponsored by Nationwide Children's Hospital. Started Jan 2015; status: terminated.
02
Drugs
rituximab
03
Conditions
nephrotic syndrome
Beyond the preview
Go deeper on NCT02390362.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02390362.